Thrombocytes And IndividuaLization of ORal Antiplatelet Treatment After Percutaneous Coronary Intervention.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Thrombosis
- Focus Pharmacodynamics
- Acronyms TAILOR
- 03 Sep 2013 Primary endpoint 'Platelet-aggregation' has been met.
- 03 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 23 Mar 2011 Actual initiation date (September 2010) added as reported by ClinicalTrials.gov.